Medical Oncology

Uzm. Dr. Bengü Dursun

Doctor and researcher Ankara Etlik Şehir Hastanesi Ankara
Breast NeoplasmsBreast Neoplasms, Male
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 3 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Breast Neoplasms, Male 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologysaglik.gov.trFrom source
  • InstitutionAnkara Etlik Şehir Hastanesisaglik.gov.trFrom source
  • Area of workBreast NeoplasmsExtracted from 3 publications · Model version —From source
  • Publications22 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0002-1433-8446ORCIDFrom source
  • Last synchronised7 November 2026 00:02https://etliksehir.saglik.gov.tr/TR-864408/klinik-doktorlarimiz.html#bengu-dursunsaglik.gov.tr

Scientific work

Publications on Breast Neoplasms

22 publications
Publications by year Most: 8, in 2026
  1. 2020: 1 publication
  2. 2021: 1 publication
  3. 2022: 1 publication
  4. 2023: 5 publications
  5. 2024: 4 publications
  6. 2025: 2 publications
  7. 2026: 8 publications

  1. Clinicopathological Correlates of High Stromal Tumor-infiltrating Lymphocytes in Luminal Breast Cancer: A Real-world Study

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-3-11 Open-access full textSource: OpenAlex

  2. Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG)

    Cancers, 2026

    DOI 10.3390/cancers18060915 PMID 41899520 1 citation (Europe PMC) Open-access full textSource: ORCID

  3. Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy

    Cancers, 2026

    DOI 10.3390/cancers18142302 PMID 42512369 Open-access full textSource: ORCID

  4. Are Changes in PET/CT SUVmax Associated with Pathologic Complete Response in Breast Cancer Patients Receiving Neoadjuvant Therapy?

    Acta Haematologica Oncologica Turcica, 2026

    DOI 10.4274/ahot.galenos.2026.2026-2-6 Open-access full textSource: ORCID

  5. Baseline vitamin D levels and progression-free survival in patients with HR+/HER2-metastatic breast cancer treated with ribociclib: a retrospective single-center analysis

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-05502-2 PMID 42340556 Open-access full textSource: ORCID

  6. Concordance Between ChatGPT and Real-World Adjuvant Chemotherapy Decisions in pT3N0 Colon Cancer

    Eurasian Journal of Medical Investigation, 2026

    DOI 10.14744/ejmi.2612508 Source: ORCID

  7. Does Timing Matter? Impact of Time to Surgery on Pathologic Response in Gastric Cancer Patients Treated with Perioperative FLOT

    Medicina, 2026

    DOI 10.3390/medicina62061080 PMID 42356093 Open-access full textSource: OpenAlex

  8. Clinical Impact of Cytomegalovirus Infection in Patients with Inflammatory Bowel Disease

    Turkish Journal of Gastroenterology, 2026

    DOI 10.5152/tjg.2026.25407 PMID 41846476 Open-access full textSource: ORCID

  9. Real-world treatment compliance and outcomes in adult patients with localized Ewing sarcoma: A single-institution retrospective study

    Medicine, 2025

    DOI 10.1097/md.0000000000043405 PMID 40696651 Open-access full textSource: OpenAlex

  10. TARE-Induced Pan-Immune Inflammation Value as a Prognostic Biomarker in Liver-Dominant Metastatic Colorectal Cancer

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14144927 PMID 40725620 3 citations (Europe PMC) Open-access full textSource: ORCID

View all 22 publications